|
BOSTON (AP) - Lawsuits over problems with Guidant heart-rhythm devices have recently grown at a rate of nearly three new cases per day, according to a regulatory filing tallying up the legal risks Boston Scientific Corp. inherited in its $27 billion Guidant Corp. acquisition.
Boston Scientific faces more than 1,175 individual and class-action lawsuits over recalls and safety warnings issued in 2005 and 2006 involving Guidant's implantable defibrillators and pacemakers, the company said in an annual filing made after markets closed Thursday.
The total is up from 842 cases when Boston Scientific filed a quarterly update with the Securities and Exchange Commission on Nov. 9. The increase amounts to 333 cases over 112 days.
|